Dealmakers are proving adept at strategic pivots while also placing emphasis on strategic alignment and pre-deal preparation, and making greater use of advanced technologies across the M&A lifecycle NEW YORK, Jan. 23, 2024 /PRNewswire/ — Today, Deloitte released the findings of its “2024 M&A Trends Survey: Mind the gap,” asking corporate and private equity (PE)… Continue reading M&A Activity Poised for a Rebound in 2024; Value of Deals Expected to Increase: Deloitte 2024 M&A Trends Survey
Category: Newswire
Plywood Market Size Projected to Reach USD 13.47 Billion through 2024 and 2028, Driven by Surge in Construction Activities | Technavio
NEW YORK, Jan. 23, 2024 /PRNewswire/ — The Global Plywood Market is set for substantial growth, with Technavio’s latest report forecasting an increase of USD 13.47 billion at a CAGR of 4.36% between 2023 and 2028. The market’s upward trajectory is fueled by a confluence of factors, including the escalating demand for residential and commercial construction,… Continue reading Plywood Market Size Projected to Reach USD 13.47 Billion through 2024 and 2028, Driven by Surge in Construction Activities | Technavio
Blues Hires New Executive to Support Customer and Partner Growth
Alistair Fulton joins Blues as Chief Operating Officer (COO) and Vice President (VP) of Ecosystem MANCHESTER, Mass., Jan. 23, 2024 /PRNewswire/ — Blues, a leader in IIoT technology enabling global connectivity solutions, today announced Alistair Fulton as its new Chief Operating Officer (COO) and Vice President (VP) of Ecosystem. In his role, Fulton will oversee the… Continue reading Blues Hires New Executive to Support Customer and Partner Growth
PEOPLES BANCORP INC. DECLARES QUARTERLY DIVIDEND
MARIETTA, Ohio, Jan. 23, 2024 /PRNewswire/ — The Board of Directors of Peoples Bancorp Inc. (“Peoples”) (Nasdaq: PEBO) declared a quarterly cash dividend of $0.39 per common share on January 22, 2024, payable on February 20, 2024, to shareholders of record on February 5, 2024. This dividend represents a payout of approximately $13.8 million, or 40.7% of Peoples’ reported… Continue reading PEOPLES BANCORP INC. DECLARES QUARTERLY DIVIDEND
Myriad Venture Partners Launches Inaugural Fund, Secures $100M in Initial Capital Commitments to Support Transformational Founders in AI, B2B Software and Clean Tech
As global venture funding for early-stage startups decreases, the investment landscape is uniquely positioned for capital deployment towards future market leaders. Born out of Xerox Ventures with a track record of success, Myriad brings decades of investment, strategy and operational expertise, and a deep corporate and investor network supporting world-class entrepreneurs shaping the future of… Continue reading Myriad Venture Partners Launches Inaugural Fund, Secures $100M in Initial Capital Commitments to Support Transformational Founders in AI, B2B Software and Clean Tech
Coors Light® Brings Chill to the Big Game with Return of Iconic Beer Train
Book a virtual seat on The Chill Train and ride in their Big Game campaign. CHICAGO, Jan. 23, 2024 /PRNewswire/ — All aboard! The Coors Light Chill Train is officially here and heading to this year’s Big Game to bring ‘chill’ to everyone, everywhere. In 2005, Coors Light’s iconic train made its debut, bringing chill… Continue reading Coors Light® Brings Chill to the Big Game with Return of Iconic Beer Train
Synchrony Reports Fourth Quarter 2023 Results
STAMFORD, Conn., Jan. 23, 2024 /PRNewswire/ — Synchrony Financial (NYSE: SYF) today announced its fourth quarter 2023 results for the period ending December 31, 2023. The earnings news release, financial tables and related materials can be found on the company’s investor relations website at https://investors.synchrony.com/financial-results. Today at 8:00 AM ET, Brian Doubles, President and Chief Executive Officer, and Brian Wenzel… Continue reading Synchrony Reports Fourth Quarter 2023 Results
Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies
Financing led by Mirae Asset Capital Life Science with participation from additional new and existing investors Funds will support advancement of lead programs through early clinical development, including Accent’s first-in-class DHX9 inhibitor and newly unveiled, potentially best-in-class KIF18A inhibitor LEXINGTON, Mass., Jan. 23, 2024 /PRNewswire/ — Accent Therapeutics, a biopharmaceutical company pioneering a new class of small… Continue reading Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies
Executive compensation and governance attorney Megan Juel joins McDonald Hopkins
CHICAGO, Jan. 23, 2024 /PRNewswire/ — McDonald Hopkins LLC, a business advocacy and advisory firm, is thrilled to announce the addition of Megan Juel as Counsel in the Business Department and as a part of the firm’s Executive Compensation and Governance Practice Group. Continue Reading Megan Juel joins McDonald Hopkins LLC “We continue to be… Continue reading Executive compensation and governance attorney Megan Juel joins McDonald Hopkins
Patient, Research and Industry Leaders Propose Biological Definition and First Biological Staging for Parkinson’s Disease
New paper in The Lancet Neurology proposes the first iteration of a research framework for defining and staging Parkinson’s disease (PD) based on biology, rather than clinical symptoms The framework defines PD based on the neuronal alpha-synuclein pathology that is a hallmark for the disease, building on the 2023 discovery of a biomarker that detects… Continue reading Patient, Research and Industry Leaders Propose Biological Definition and First Biological Staging for Parkinson’s Disease